DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

Bibliographische Detailangaben

Veröffentlicht in:	Journal for immunotherapy of cancer 2014-11, Vol.2 (S3), p.O17-O17, Article O17
Hauptverfasser:	Humeau, Laurent, Trimble, Cornelia, Morrow, Matthew, Shen, Xuefei, Dallas, Michael, Weiner, David, Boyer, Jean, Yan, Jian, Kraynyak, Kimberly, Sylvester, Albert, Giffear, Mary, Marcozzi-Pierce, Kathy, Shah, Divya, Broderick, Kate, Khan, Amir, Lee, Jessica, Sardesai, Niranjan, Bargarazzi, Mark
Format:	Artikel
Sprache:	eng
Schlagworte:	Double-blind studies Human papillomavirus Oral Presentation Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!